Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura
SR Cataland, F Peyvandi, PM Mannucci, B Lämmle… - 2012 - pubmed.ncbi.nlm.nih.gov
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in
patients with thrombotic thrombocytopenic purpura Initial experience from a double-blind,
placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic
thrombocytopenic purpura Am J Hematol. 2012 Apr;87(4):430-2. doi: 10.1002/ajh.23106. Epub
2012 Feb 24. Authors Spero R Cataland, Flora Peyvandi, Pier M Mannucci, Bernhard Lämmle,
Johanna A Kremer Hovinga, Samuel J Machin, Marie Scully, Gail Rock, James C Gilbert …
patients with thrombotic thrombocytopenic purpura Initial experience from a double-blind,
placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic
thrombocytopenic purpura Am J Hematol. 2012 Apr;87(4):430-2. doi: 10.1002/ajh.23106. Epub
2012 Feb 24. Authors Spero R Cataland, Flora Peyvandi, Pier M Mannucci, Bernhard Lämmle,
Johanna A Kremer Hovinga, Samuel J Machin, Marie Scully, Gail Rock, James C Gilbert …
